Universit catholique de Louvain Louvain Drug Research Institute, Brussels, Belgium.
Drugs Aging. 2012 Jun 1;29(6):495-510. doi: 10.2165/11631720-000000000-00000.
Prescription of medicines is a fundamental component of the care of older people, but evidence suggests that pharmacotherapy in this population is often inappropriate. Pharmacists have been involved in different approaches for the optimization of prescribing and rational medication use in older people. This article describes the different models of care in which pharmacists are involved in the optimization of pharmacotherapy in older people, and reviews the impact of these approaches on both process and outcome measures. The provision of pharmaceutical care, medication reviews and educational interventions by pharmacists in the nursing home, ambulatory and acute care settings are discussed. We selected systematic reviews, reviews and original studies, and for the latter, we focused more specifically on European publications published between 2001 and 2011. From the literature reviewed, it is clear that when pharmacists play a proactive role in performing medication reviews and in the active education of other healthcare professionals, pharmacotherapy for older patients is improved. However, the evidence of the impact of pharmacists' interventions on health outcomes, quality of life or cost effectiveness of care is mixed. Better results have been reported when pharmacists are skilled and work in the context of a multidisciplinary team. Opportunities remain for multicentre, European-based, pharmacist-intervention trials in all settings, to determine the effectiveness and economic benefit of pharmacist involvement in the optimization of pharmacotherapy in older people.
药物处方是老年人护理的基本组成部分,但有证据表明,该人群的药物治疗往往并不恰当。药剂师已经参与了不同的方法来优化老年人的药物治疗和合理用药。本文描述了药剂师参与优化老年人药物治疗的不同护理模式,并回顾了这些方法对过程和结果测量的影响。讨论了药剂师在养老院、门诊和急性护理环境中提供药物治疗、药物审查和教育干预的情况。我们选择了系统评价、综述和原始研究,对于后者,我们更专注于 2001 年至 2011 年期间发表的欧洲出版物。从回顾的文献中可以清楚地看出,当药剂师在进行药物审查和积极教育其他医疗保健专业人员方面发挥积极作用时,老年患者的药物治疗会得到改善。然而,药剂师干预对健康结果、生活质量或护理成本效益的影响的证据是混杂的。当药剂师具备技能并在多学科团队的背景下工作时,报告的结果会更好。在所有环境中,仍然有机会进行以药剂师为干预者的、基于欧洲的、多中心的试验,以确定药剂师参与优化老年人药物治疗的有效性和经济效益。